MRI guidance minimizes toxicity in prostate cancer radiotherapy
21 Sep 2019
The team used ViewRay's MRIdian system to deliver MR-guided hypofractionated radiotherapy to patients with prostate cancer. (Courtesy: ViewRay)
Hypofractionated stereotactic body radiotherapy (SBRT) combined with MRI guidance to treat prostate
You’ve reached the limit of what you can view on Physics World without registering
If you already have an account on Physics World, then please sign in to continue reading
If you do not yet have an account, please register so you can
Access more than 20 years of online content
Choose which e-mail newsletters you would like to receive
Cynthia E Keen is a freelance journalist specializing in medicine and healthcare-related innovations